80 related articles for article (PubMed ID: 6164619)
1. [Do the HLA-A2 genes prevent tumor development? A hypothesis].
Májský A; Abrahámová J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):90-6. PubMed ID: 6164619
[TBL] [Abstract][Full Text] [Related]
2. [The presence of HLA-A2 antigens on lymphocytes - protection against tumors?].
Májský A; Abrahámová J
Cas Lek Cesk; 1980 Jan; 119(2):47-50. PubMed ID: 6245809
[No Abstract] [Full Text] [Related]
3. [The HLA system in Wilms' tumor and in neuroblastoma].
Abrahámová J; Májský A; Koutecký J
Cesk Pediatr; 1979 May; 34(5):268-70. PubMed ID: 221123
[No Abstract] [Full Text] [Related]
4. [Chromosomal study of 20 embryonic tumors after short term culture].
Rousseau MF
Biomedicine; 1973 Jun; 19(6):275-80. PubMed ID: 4356547
[No Abstract] [Full Text] [Related]
5. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
6. [HLA system and Wilms' tumour--familial study].
Abrahámová J; Májský A; Korínková P; Koutecký J
Cas Lek Cesk; 1982 Jun; 121(25):791-4. PubMed ID: 6288245
[No Abstract] [Full Text] [Related]
7. Father-son testicular cancer, case report.
Musella R; Giaccone G; D'Ambrosio E; Calciati A
Tumori; 1983 Jun; 69(3):269-70. PubMed ID: 6868144
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
9. HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer.
Peoples GE; Goedegebuure PS; Andrews JV; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5481-91. PubMed ID: 8228240
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients.
Hueman MT; Dehqanzada ZA; Novak TE; Gurney JM; Woll MM; Ryan GB; Storrer CE; Fisher C; McLeod DG; Ioannides CG; Ponniah S; Peoples GE
Clin Cancer Res; 2005 Oct; 11(20):7470-9. PubMed ID: 16243821
[TBL] [Abstract][Full Text] [Related]
11. [Detection of common determinants of the HLA antigens A2 and B17 using absorption of immune human sera].
Májsky A; Korínková P
Cas Lek Cesk; 1983 Feb; 122(6):169-71. PubMed ID: 6187457
[No Abstract] [Full Text] [Related]
12. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors.
Pérez-Martínez A; Leung W; Muñoz E; Iyengar R; Ramírez M; Vicario JL; Lassaletta A; Sevilla J; González-Vicent M; Madero L; Díaz-Pérez MA
Pediatr Blood Cancer; 2009 Jul; 53(1):120-4. PubMed ID: 19215002
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
[TBL] [Abstract][Full Text] [Related]
15. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
16. [HLA-antigens in germ cell tumors of various sites].
Abrahámová J; Májský A; Koutecký J
Onkologie; 1981 Feb; 4(1):19-20. PubMed ID: 7012730
[TBL] [Abstract][Full Text] [Related]
17. [HLA antigens in patients with testicular germ cell tumors].
Nishimura K; Miura H; Yasunaga Y; Takatera H; Fujioka H; Takahara S; Tsuji T; Sada M
Hinyokika Kiyo; 1996 Feb; 42(2):95-9. PubMed ID: 8712095
[TBL] [Abstract][Full Text] [Related]
18. [The origin of HLA antigens in thrombocytes].
Korínková P
Vnitr Lek; 1989 Sep; 35(9):880-4. PubMed ID: 2683366
[TBL] [Abstract][Full Text] [Related]
19. HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney.
Pfeffer PF; Sødal G; Thorsby E
Scand J Urol Nephrol Suppl; 1981; 64():72-8. PubMed ID: 6216585
[TBL] [Abstract][Full Text] [Related]
20. [Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes].
Nonomura N; Imazu T; Harada Y; Nozawa M; Ono Y; Fukui T; Nishimura K; Okuyama A
Hinyokika Kiyo; 1999 Aug; 45(8):593-7. PubMed ID: 10500969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
